Navigation Links
FDA Panel Says No to Avastin for Advanced Breast Cancer
Date:12/5/2007

Drug has significant risks, and its benefits are still debated, experts say

WEDNESDAY, Dec. 5 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel recommended Wednesday that the cancer drug Avastin should not be used to treat women with advanced breast cancer.

In a close vote, 5-4, the advisers decided the drug's ability to slow down the growth of tumors did not outweigh the increased risk of blood clots and other cardiovascular troubles among users, the Associated Press reported. In rare cases, patients taking Avastin with standard chemotherapy have died.

Avastin was approved to treat colon cancer in 2004, and lung cancer in 2006. It works by cutting off the tumor's blood supply.

"Everybody wants to offer metastic breast cancer patients hope, but we shouldn't offer them false hope," panel member Natalie Compagni-Portis, a patient representative with Breast Cancer Action in San Francisco, said during the meeting, according to the AP. "We have to raise the bar in terms of safety."

"These patients are terminal, and it's our job to make their lives better, not to say that it's OK to have a stroke or that it's manageable," Maha Hussain, an oncologist at the University of Michigan and the advisory panel's chairwoman, said during the meeting. "You didn't show that patients are living better or that they're living longer."

In trial results submitted to the FDA by the drug's U.S. maker, Genentech Inc., use of Avastin (bevacizumab) did boost the progression-free survival of women with advanced breast cancer by an average of 5.5 months, when combined with the chemotherapy drug paclitaxel. Progression-free survival refers to survival without any advancement of the malignancy.

However, the same Genentech study of 722 patients showed that patients reaped no gain in terms of their overall survival after taking Avastin.

Another company-funded trial, this ti
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Virginia Tech Review Panel Calls For Reform of Mental Health Treatment Law
2. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
3. Patient Safety Authority Board of Directors Names Infection Advisory Panel
4. Partners Rx Chief Pharmacy Officer, Richard Bullard on Panel Discussion at the Fall 2007 Managed Markets Summit (MMS) in Phoenix, AZ.
5. Billians HealthDATA GM Speaking on Dreamforce 07 Panel
6. FDA Panel Recommends Approval of SyntheMeds REPEL-CV(R) Adhesion Barrier for Pediatric Patients
7. Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers
8. Health Courts Critic to be Featured Speaker at Wyoming Patient Safety Panel
9. FDA Panel Mulls Ban on Kids Cold Medicines
10. FDA Panel Weighs Ban on Kids Cold Medicines
11. FDA Panel Recommends Ban on Cold Medicines for Kids
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Panel Says No to Avastin for Advanced Breast Cancer
(Date:8/23/2014)... (PRWEB) August 23, 2014 GranuFlo ... 2012 GranuFlo and NaturaLyte dialysis concentrate recall continue ... in U.S. District Court, District of Massachusetts, Bernstein ... report issued by the U.S. Judicial Panel on ... 2,028 claims are pending in the proceeding. In ...
(Date:8/23/2014)... 2014 According to the new ... Application and Geography - Regional Trends & Forecast ... Market with an analysis and forecast of value ... of electronic adhesives by applications and geography are ... market data tables and 26 figures spread through ...
(Date:8/23/2014)... PA (PRWEB) August 23, 2014 "When ... sometimes comes into contact with the dirty water inside ... the seat itself," said one of two inventors from ... to germs, we developed this protective device." , They ... unsanitary toilet surfaces, including the water, bowl and seat. ...
(Date:8/23/2014)... 2014 Hundreds of Wright hip ... of individuals who were allegedly harmed by devices ... to move forward in the U.S. District Court, ... According to an Order dated August 19th, the ... would allow the litigation’s first case to go ...
(Date:8/23/2014)... York, NY (PRWEB) August 23, 2014 ... (NYT) reported on a data breach suffered by ... that saw the compromise of 4.5 million records containing ... social security numbers. According to Mandiant, who was engaged ... emanated from an advanced group of cyber attackers ...
Breaking Medicine News(10 mins):Health News:GranuFlo Lawsuits Mount in Federal Litigation, as Filings Surpass 2,000, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuits Mount in Federal Litigation, as Filings Surpass 2,000, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuits Mount in Federal Litigation, as Filings Surpass 2,000, Bernstein Liebhard LLP Reports 4Health News:Electronic Adhesives Market Poised to Reach $5.5 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Electronic Adhesives Market Poised to Reach $5.5 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 2Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 3Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 4Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 2Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 3Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 4
... cells to spread from a primary site, to form ... process in which cell motility and invasion play a ... develops is identification of the molecules, and characterisation of ... mechanisms have been poorly understood. Now, a team of ...
... with diabetes have the weight-loss surgery? , , SUNDAY, Dec. ... bypass surgery extends the lives of obese patients is ... go under the knife and who shouldn,t. , ... patients who traditionally haven,t been candidates for the weight-loss ...
... breast cancer prevention study using exemestane (Aromasin) finds an ... II study details reported today, by Jennifer Eng-Wong, MD, ... Center at the San Antonio Breast Cancer Symposium, examines ... at an increased risk of developing breast cancer based ...
... transcript of President Bush,s weekly radio address to the nation: , ... week, our country received good news in the fight against illegal drugs. ... to decline -- and that we are making good progress in our ... , , Substance abuse is a serious ...
... leading healthcare provider of interim and executive placement and consulting solutions, ... board and CEO services. Formerly vice president, senior executive search, Noland ... for hospitals, home care companies, health systems and national healthcare organizations. ... ...
... retail locations joining national partners in effort to raise $5 ... Dec. 12 National partners from the 17th annual ... Memphis today to celebrate raising more than $2.4 million to ... , , Companies represented at ...
Cached Medicine News:Health News:Gastric Bypass Success Sparks Debate 2Health News:Gastric Bypass Success Sparks Debate 3Health News:Radio Address by President Bush to the Nation 2Health News:Radio Address by President Bush to the Nation 3Health News:Noland Named Vice President, Board & CEO Services for B. E. Smith 2Health News:More Than $2.4 Million Raised by National Halloween Promotion Partners to Help St. Jude Fight Childhood Cancer 2
(Date:8/21/2014)... 21, 2014 The spinal column is one of ... Signals carried to and from the brain through the column ... system. Injury or ailment here can be life altering, and ... of control over their body. Though back injury and disease ... there are more options available to make things better than ...
(Date:8/21/2014)... , Aug. 21, 2014  Decision Resources ...  physicians in Brazil and ... clinical guidelines and commonly prescribe long-acting beta-agonist (LABA)- ... they do so within current severe cost/coverage constraints. ... that are expected to launch in these countries—which ...
(Date:8/21/2014)... , Aug. 21, 2014  Seventy-one percent of Americans believe ... is a serious public health and safety issue in ... a survey released today by Repass & Partners, a ... "Americans understand the severity of the prescription medication abuse ... with this very serious health situation facing our country," ...
Breaking Medicine Technology:Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3
... Reportlinker.com announces that a new market research ... Insulin Patch Pumps ... inhaled insulin market in 2008 has resulted in ... now appears that the patch pump – a ...
... Reportlinker.com announces that a new market ... The Outlook for Pharmaceuticals ... http://www.reportlinker.com/p0203102/The-Outlook-for-Pharmaceuticals-in-Central-Asia.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory These reports provide ... most populous countries in the world and ...
Cached Medicine Technology:Insulin Patch Pumps 2The Outlook for Pharmaceuticals in Central Asia 2The Outlook for Pharmaceuticals in Central Asia 3The Outlook for Pharmaceuticals in Central Asia 4
Platelet agitator....
I-125 competitive RIA kit for the detection of Progesterone....
... quantitative determination of progesterone ... Progesterone EIA is ... of competitive binding between ... specimen and progesterone-HRP conjugate ...
ELISA for the detection of Insulin....
Medicine Products: